Vimarsana
Biggest News Aggregation in the World

Equity Research Associate News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Equity Research Associate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Equity Research Associate Today - Breaking & Trending Today

StevenDouglas Promotes Ross Cohen to Managing Director with Continued Focus on Financial Services Expansion - Vimarsana News

StevenDouglas Promotes Ross Cohen to Managing Director with Continued Focus on Financial Services Expansion

Fort Lauderdale, Florida (PRWEB) January 25, 2023 -- StevenDouglas promotes Ross Cohento Managing Director of the Financial Services Search Division as part

Source: prweb.com
OSE Immunotherapeutics Announces Participation In Upcoming Investor Conferences - Vimarsana News

OSE Immunotherapeutics Announces Participation In Upcoming Investor Conferences

Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) announced today that the leadership team will attend several investor conferences in September and October 2022. Conference

OSE Immunotherapeutics Announces Participation In Upcoming Investor Conferences - Vimarsana News

OSE Immunotherapeutics Announces Participation In Upcoming Investor Conferences

NANTES, France--(BUSINESS WIRE)--Regulatory News:OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) announced today that the leadership team will attend several investor conferences in September and October 2022.Conference details:- H.C. Wainwright 24th Annual Global Investment ConferenceFormat: Fireside cha...

CarTrade makes weak stock market debut, lists below issue price - Vimarsana News

CarTrade makes weak stock market debut, lists below issue price

CarTrade Tech Ltd made a weak debut on the stock market on Friday and got listed below the issue price of Rs 1,618 per share.On the BSE, it was listed at Rs 1,600 per share.Around 12.40 p.m., shares of the company were trading at Rs 1,552.05, ...

Tatva Chintan Pharma Chem's GMP rises to 64% as IPO opens - Vimarsana News

Tatva Chintan Pharma Chem's GMP rises to 64% as IPO opens

Tatva Chintan Pharma Chem’s GMP rises to 64% as IPO opens SECTIONS Share Synopsis Most analysts have advised investors to subscribe to the Rs 500 crore initial public offering (IPO). The price band of the issue has been fixed at Rs 1,073-1,083 a share. Bids can be made for a minimum of 13 shares and in multiples thereafter. iStock The company is going to list at a PE of 41.62 times with a market-cap of Rs 24,00.47 crore, while its peers – namely Aarti Industries and Navin Fluorine International – trade at PE values of 59.54 times and 73.95 times, respectively. Related NEW DELHI: While t...